Correlation Between Kaleido Biosciences and Sio Gene
Can any of the company-specific risk be diversified away by investing in both Kaleido Biosciences and Sio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kaleido Biosciences and Sio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kaleido Biosciences and Sio Gene Therapies, you can compare the effects of market volatilities on Kaleido Biosciences and Sio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kaleido Biosciences with a short position of Sio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kaleido Biosciences and Sio Gene.
Diversification Opportunities for Kaleido Biosciences and Sio Gene
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Kaleido and Sio is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Kaleido Biosciences and Sio Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sio Gene Therapies and Kaleido Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kaleido Biosciences are associated (or correlated) with Sio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sio Gene Therapies has no effect on the direction of Kaleido Biosciences i.e., Kaleido Biosciences and Sio Gene go up and down completely randomly.
Pair Corralation between Kaleido Biosciences and Sio Gene
If you would invest 40.00 in Sio Gene Therapies on September 12, 2024 and sell it today you would earn a total of 0.00 from holding Sio Gene Therapies or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kaleido Biosciences vs. Sio Gene Therapies
Performance |
| Timeline |
| Kaleido Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Sio Gene Therapies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kaleido Biosciences and Sio Gene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kaleido Biosciences and Sio Gene
The main advantage of trading using opposite Kaleido Biosciences and Sio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kaleido Biosciences position performs unexpectedly, Sio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sio Gene will offset losses from the drop in Sio Gene's long position.| Kaleido Biosciences vs. Inhibikase Therapeutics | Kaleido Biosciences vs. Tempest Therapeutics | Kaleido Biosciences vs. CytomX Therapeutics | Kaleido Biosciences vs. Assembly Biosciences |
| Sio Gene vs. CytomX Therapeutics | Sio Gene vs. Assembly Biosciences | Sio Gene vs. Instil Bio | Sio Gene vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |